中文 | English
Return
Total: 399 , 1/40
Show Home Prev Next End page: GO
Author:(Guo-qiang SUN)

1.​ Exploration and Practice of a Generative AI-assisted Four-dimensional Integration Platform of “Teaching, Learning, Evaluation, and Research” for The Biochemistry and Molecular Biology Courses

Pan CHEN ; Yang XI ; Xiao-Feng JIN ; De-Sen SUN ; Qiang CHEN ; Jun-Ming GUO

Progress in Biochemistry and Biophysics 2026;53(3):789-800

2.miR-27a-3p promotes the proliferation of human hypertrophic scar fibroblasts by regulating mitogen-activated protein kinase signaling pathway

Jun LI ; Jingjing GONG ; Guobin SUN ; Rui GUO ; Yang DING ; Lijuan QIANG ; Xiaoli ZHANG ; Zhanhai FANG

Chinese Journal of Tissue Engineering Research 2025;29(8):1609-1617

3.Selection of health utility measurement tools for high-risk populations with cardiovascular disease:Application validation of EQ-5D-5L and SF-6Dv2

Ju SUN ; Qian GUO ; Hao-miao LI ; Qiang YAO ; Shu-zhen ZHU ; Jun-lin LI

Chinese Journal of Health Policy 2025;18(8):20-28

4.Clinical effect of sofosbuvir-velpatasvir on treatment of patients with genotype 3 chronic hepatic C and liver cirrhosis

MAIMAITIJIANG·WUBULIAISHAN ; Hong YU ; AMINAI·AIBI ; Zhuanguo WANG ; Jing DOU ; Wei SUN ; Zhonghui NING ; Xiaobo WANG ; Qiang XU ; Xiaozhong WANG ; Hongyan ZHANG ; Feng GUO

Chinese Journal of Nosocomiology 2025;35(9):1322-1326

5.Value of healthcare failure mode and effect analysis mode combined with enhanced management of link quality in centralized processing of rigid endoscopic instruments

Fei NING ; Qiang CHEN ; Lei GUO ; Yang ZHANG ; Yuanyuan XIANG ; Fang LIU ; Cai SUN

Chinese Journal of Nosocomiology 2025;35(10):1567-1571

6.Selection of health utility measurement tools for high-risk populations with cardiovascular disease:Application validation of EQ-5D-5L and SF-6Dv2

Ju SUN ; Qian GUO ; Hao-miao LI ; Qiang YAO ; Shu-zhen ZHU ; Jun-lin LI

Chinese Journal of Health Policy 2025;18(8):20-28

7.Clinical effect of sofosbuvir-velpatasvir on treatment of patients with genotype 3 chronic hepatic C and liver cirrhosis

MAIMAITIJIANG·WUBULIAISHAN ; Hong YU ; AMINAI·AIBI ; Zhuanguo WANG ; Jing DOU ; Wei SUN ; Zhonghui NING ; Xiaobo WANG ; Qiang XU ; Xiaozhong WANG ; Hongyan ZHANG ; Feng GUO

Chinese Journal of Nosocomiology 2025;35(9):1322-1326

8.Value of healthcare failure mode and effect analysis mode combined with enhanced management of link quality in centralized processing of rigid endoscopic instruments

Fei NING ; Qiang CHEN ; Lei GUO ; Yang ZHANG ; Yuanyuan XIANG ; Fang LIU ; Cai SUN

Chinese Journal of Nosocomiology 2025;35(10):1567-1571

9.Percutaneous coronary intervention vs . medical therapy in patients on dialysis with coronary artery disease in China.

Enmin XIE ; Yaxin WU ; Zixiang YE ; Yong HE ; Hesong ZENG ; Jianfang LUO ; Mulei CHEN ; Wenyue PANG ; Yanmin XU ; Chuanyu GAO ; Xiaogang GUO ; Lin CAI ; Qingwei JI ; Yining YANG ; Di WU ; Yiqiang YUAN ; Jing WAN ; Yuliang MA ; Jun ZHANG ; Zhimin DU ; Qing YANG ; Jinsong CHENG ; Chunhua DING ; Xiang MA ; Chunlin YIN ; Zeyuan FAN ; Qiang TANG ; Yue LI ; Lihua SUN ; Chengzhi LU ; Jufang CHI ; Zhuhua YAO ; Yanxiang GAO ; Changan YU ; Jingyi REN ; Jingang ZHENG

Chinese Medical Journal 2025;138(3):301-310

10.Effect of Shufeng Jiedu Capsules on Relieving Influenza Virus Pneumonia by Suppressing TLR/NF-κB Pathway in Respiratory Epithelial Cells

Zihan GENG ; Lei BAO ; Shan CAO ; Qiang ZHU ; Jun PAN ; Shuran LI ; Ronghua ZHAO ; Jing SUN ; Yanyan BAO ; Shaoqiu MU ; Xiaolan CUI ; Shanshan GUO

Chinese Journal of Experimental Traditional Medical Formulae 2025;31(24):61-68

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 399 , 1/40 Show Home Prev Next End page: GO